Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erlotinib induced skin rash spares skin in previous radiotherapy field.

× No keyword cloud information.

13 in total

Review 1. [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

Authors: P A Gerber; B A Buhren; S Kürle; B Homey
Journal: Hautarzt Date: 2010-08 Impact factor: 0.751

Review 2. Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy.

Authors: Devron R Shah; Rashmi R Shah; Joel Morganroth
Journal: Drug Saf Date: 2013-06 Impact factor: 5.606

3. EMPACT syndrome: limited evidence despite a high-risk cohort.

Authors: Andrew J Bishop; Maria Chang; Mario E Lacouture; Christopher A Barker
Journal: J Neurooncol Date: 2014-05-03 Impact factor: 4.130

4. Erlotinib-induced rash spares previously irradiated skin.

Authors: Irene M Lips; Mariska E Y Koster; Ronald H Houwing; Ernest J A Vonk
Journal: Strahlenther Onkol Date: 2011-07-25 Impact factor: 3.621

5. A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients.

Authors: Ahmed Abbas Suleiman; Sebastian Frechen; Matthias Scheffler; Thomas Zander; Lucia Nogova; Martin Kocher; Ulrich Jaehde; Jürgen Wolf; Uwe Fuhr
Journal: AAPS J Date: 2015-08-19 Impact factor: 4.009

6. Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature.

Authors: Madhava R Kanakamedala; Satyaseelan Packianathan; Srinivasan Vijayakumar
Journal: Radiat Oncol Date: 2010-05-17 Impact factor: 3.481

Review 7. Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors: Tianhong Li; Roman Perez-Soler
Journal: Target Oncol Date: 2009-05-19 Impact factor: 4.493

8. Irradiated fields spared Stevens-Johnson syndrome in a patient undergoing radiotherapy for bone metastases.

Authors: Daniela Musio; Elisabetta Parisi; Francesco Dionisi; Giuseppe Parisi; Rossella Caiazzo; Nadia Bulzonetti; Miriam Lichtner; Nicola Raffetto; Vincenzo Vullo; Enzo Banelli
Journal: Jpn J Radiol Date: 2009-03-12 Impact factor: 2.374

9. Radiotherapy and erlotinib combined: review of the preclinical and clinical evidence.

Authors: Vivek K Mehta
Journal: Front Oncol Date: 2012-04-10 Impact factor: 6.244

Review 10. Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.

Authors: L Peuvrel; C Bachmeyer; Z Reguiai; J B Bachet; T André; R J Bensadoun; O Bouché; M Ychou; B Dréno
Journal: Support Care Cancer Date: 2012-02-24 Impact factor: 3.359